NYSE: RCUS
Arcus Biosciences insiders
The officers, directors and 10% owners of Arcus Biosciences, Inc. who hold the most stock, valued at the live RCUS price.
$15.78
RCUS today +$20K (+0.13%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their RCUS stock
- $569M
- Market value
- $2.31B
- Held by ranked insiders
- 24.6%
Insiders by value of RCUS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 10% owner | 31,424,760 | $496M | 21.5% | Corporate |
| 2 | Terry J. Rosen | Chief Executive Officer | 2,236,409 | $35.3M | 1.53% | 3307th |
| 3 | Juan C. Jaen | President | 1,200,531 | $18.9M | 0.82% | 5424th |
| 4 | Yasunori Kaneko | Director | 957,955 | $15.1M | 0.65% | 6409th |
| 5 | Jennifer Jarrett | Chief Operating Officer | 224,024 | $3.5M | 0.15% | 5979th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Arcus Biosciences; see each profile for the filing.